Hirudoid

Hirudoid is a cutaneous medication whose active ingredient is mucopolysaccharide polysulfuric acid ester; it is supplied as a topical preparation, with the specific strength not publicly disclosed. The product is marketed in the European Union and is intended for external use on the skin. It is classified as a topical anti‑inflammatory and anti‑edema agent, though its exact therapeutic class is not formally assigned.

Hirudoid is applied to the skin for several superficial conditions where reduction of swelling or bruising is desired. It is commonly employed in the following situations: - Management of minor bruises (contusions) and superficial hematomas. - Relief of localized swelling (edema) caused by trauma or minor injuries. - Adjunctive treatment of mild inflammatory skin conditions such as sprains or strains. - Supportive care for postoperative or post‑procedural skin discoloration. - Temporary alleviation of discomfort associated with minor soft‑tissue injuries.

Adverse reactions to Hirudoid are generally mild and limited to the application site, but rare serious events have been reported.

Common: - Mild skin irritation or redness at the site of application. - Itching or mild pruritus. - Dryness or peeling of the treated skin. - Transient burning sensation.

Serious: - Allergic contact dermatitis presenting with swelling, vesicles, or rash. - Severe skin necrosis (extremely rare). - Systemic hypersensitivity reactions such as urticaria or angioedema.

Before using Hirudoid, consider the following safety measures: - Avoid application on broken, infected, or ulcerated skin. - Do not use on mucous membranes, eyes, or genital areas. - Discontinue use if signs of an allergic reaction develop. - Keep the product out of reach of children; accidental ingestion may cause unknown effects. - Consult a healthcare professional before use during pregnancy, lactation, or in patients with known hypersensitivity to sulfated polysaccharides. - Store at room temperature, protected from excessive heat and moisture.

While systemic interactions are unlikely due to minimal absorption, certain topical agents may affect Hirudoid's safety or efficacy.

Avoid: - Concurrent use with other potent topical corticosteroids on the same area. - Application over skin treated with chemical peels or abrasive procedures.

Use with caution: - Combination with other anti‑inflammatory gels or creams may increase irritation risk. - Use alongside occlusive dressings, which could enhance local drug concentration. - Application on areas treated with phototherapy or laser therapy. - Use in patients using systemic anticoagulants, as local bruising may be more pronounced.